Metraipolis › archive › dc_50bafa24a7be

Piperazine Derivatives: A Privileged Scaffold in Modern Synthesis and Medicinal Chemistry — Europe PMC PMID:41555571

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41555571
DOI
10.1002/open.202500366
License (as archived)
solo-consultazione
Archived
2026-11-07T05:07:57.700Z
SHA-256 of the archived text
865a7537206bfc0e59867ee6ab3ba321be28229df2817e9ecd83cc0d432b8ceb
Stable URL of this page
https://metraipolis.com/documento/dc_50bafa24a7be

How to cite

Piperazine Derivatives: A Privileged Scaffold in Modern Synthesis and Medicinal Chemistry — Europe PMC PMID:41555571 — Europe PMC (en), https://europepmc.org/article/MED/41555571 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_50bafa24a7be (Metraipolis archive dc_50bafa24a7be, sha256 865a7537206bfc0e59867ee6ab3ba321be28229df2817e9ecd83cc0d432b8ceb)
BibTeX
@misc{dc50bafa24a7be,
  title = {Piperazine Derivatives: A Privileged Scaffold in Modern Synthesis and Medicinal Chemistry — Europe PMC PMID:41555571},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41555571},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_50bafa24a7be; sha256 865a7537206bfc0e59867ee6ab3ba321be28229df2817e9ecd83cc0d432b8ceb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41555571. Agents can read the archived copy with the MCP tool read_document.